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Abstract
The synthesis of dipyrazolo[1,5-a:4',3'-c]pyridines is described. Easily obtainable 5-alkynylpyrazole-4-carbaldehydes, p-toluenesul-
fonyl hydrazide, and an aldehyde or ketone containing an α-hydrogen atom were reacted in a silver triflate catalyzed multicompo-
nent reaction affording new tricyclic compounds with a dipyrazolo[1,5-a:4',3'-c]pyridine core. Detailed NMR spectroscopic investi-
gations (1H, 13C and 15N) were undertaken with all obtained compounds.
Introduction
Condensed pyrazole scaffolds are important substructures of
compounds with biological activity and can be found in some
well-known drug molecules, such as, for example, Sildenafil (a
pyrazolo[4,3-d]pyrimidine) [1,2], Allopurinol (a pyrazolo[3,4-
d]pyrimidin-4-one) [3], Zaleplon (a pyrazolo[1,5-a]pyrimidine)
[4], and Zolazepam (a pyrazolo[3,4-e][1,4]diazepine derivative,
used in veterinary medicine) [5]. Particularly pyrazolopyrimi-
dines are a very frequently accessed class of compounds [6]
with the particular importance of the pyrazolo[3,4-d]pyrimidine
core, which can closely mimic the purine system of adenosine
and, thus, has been incorporated in various compounds
impairing protein kinases and ATPases [7-9]. Moreover, a large
variety of additional fused pyrazoles exhibit interesting bio-
logical activities, such as, pyrazolo[1,5-a]quinolones [10], pyra-
zolo[4,3-c]quinolones [11], pyrazolo[5,1-a]isoquinolines [12],
and thieno[2,3-c]pyrazoles [13]. In view of these facts as well
as due to our continuing interest in the exploration of useful but
unused chemical space, which has become a paradigm of
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Scheme 1: Intermediate reactions of pyrazole-4-carbaldehyde 1a.
contemporary medicinal chemistry [14], we have devoted some
effort to the construction of novel condensed heterocyclic
systems containing pyrazole substructures. Apart from a series
of publications dealing with the construction of pyrazole
analogues of xanthones and related systems [15-20] we
recently described the synthesis of pyrano[4,3-c]pyrazol-4(1H)-
ones and -4(2H)-ones [21], 1,5-dihydro- resp. 2,5-dihydro-
4 H - p y r a z o l o [ 4 , 3 - c ] p y r i d i n - 4 - o n e s  [ 2 0 ] ,  a n d
pyrazolo[4,3-c]pyridines [22]. In continuation of these studies
we herein present the synthesis and detailed NMR spectro-
scopic characterization of the new heterocyclic system
dipyrazolo[1,5-a:4',3'-c]pyridine. The access to the latter was
achieved by a multicomponent reaction (MCR) starting from
5-alkynylpyrazole-4-carbaldehydes. Such MCRs, although
being present since the early days of organic chemistry, nowa-
days attract an increasing interest because of their unmatched
synthetic efficiency, which permits the construction of complex
molecules in an elegant and sufficient manner [23-26].
Results and Discussion
Chemistry
The starting compounds for the construction of the title com-
pounds are the 5-alkynylpyrazole-4-carbaldehydes 1. Their syn-
thesis from easily accessible 2-pyrazolin-5-ones through
Vilsmeier formylation (with concomitant transformation of the
oxygen into a chlorine substituent), followed by Sonogashira
cross-coupling reaction of the obtained 5-chloropyrazole-4-
carbaldehydes with appropriate alkynes, has been described by
us in a former publication [21]. Compounds 1 containing an
alkyne function and a nucleophilic substituent in the ortho pos-
ition of the pyrazole system are valuable precursors for the
construction of corresponding annulated systems. In order to
employ this arrangement of functionalities for the latter
purpose, we adapted the approach of Wu and co-workers, who
described the synthesis of H-pyrazolo[5,1-a]isoquinolines by a
one-pot tandem reaction of 2-alkynylbenzaldehydes, sulfonohy-
drazide, and ketones or aldehydes [27]. In our case, application
of pyrazolecarbaldehydes 1 should enable access to the desired
dipyrazolo[1,5-a:4',3'-c]pyridines 5.
In order to test the reaction conditions, firstly each step of the
multicomponent reaction was carried out separately. According
to the strategy, pyrazole-4-carbaldehyde 1a was primarily
condensed with p-toluenesulfonyl hydrazide affording
hydrazide 2a in 97% yield (Scheme 1). Secondly, two steps of
the applied strategy were performed at once: condensation of 1a
with p-toluenesulfonyl hydrazide and subsequent 6-endo-dig
cyclization [28] of intermediate 2a in the presence of silver
triflate produced p-toluenesulfonylazamide 3a in 91% yield
(Scheme 1). The reaction of intermediate 3a with CH-acidic
aldehydes or ketones in the presence of base would lead to
various dipyrazolo[1,5-a:4',3'-c]pyridines 5.
Thus, after these results, we decided to explore the one-pot
tandem reaction with various 5-alkynylpyrazole-4-carbalde-
hydes 1, p-toluenesulfonyl hydrazide and butyraldehyde (4a).
As alkynyl functions, phenylethynyl (1a,b), 3-thienylethynyl
(1c,d) and hex-1-ynyl (1e,f) were employed; silver triflate was
used as the catalyst and K3PO4 as a base, needed for the forma-
tion of the second pyrazole ring. In this way, the
dipyrazolo[1,5-a:4',3'-c]pyridines 5a–f were achieved in yields
of 44–83% (Table 1, entries 1–6). Replacement of butyralde-
hyde by propionaldehyde (4b) or 3-phenylpropanal (4c)
afforded the corresponding tricyclic products 5g, 5h and 5i in
59–73% yield, respectively (Table 1, entries 7–9). Lastly, appli-
cation of the cyclic ketones cyclopentanone (4d), cyclohexa-
none (4e) and 2-methylcyclohexanone (4f) as carbonyl compo-
nents resulted in the formation of tetracycles 5j–l in acceptable
yields (Table 1, entries 10–12).
NMR spectroscopic investigations
The NMR spectroscopic data of all compounds described in this
study are given in Supporting Information File 1. Unequivocal
assignment of resonances was carried out by the combined
application of various standard NMR spectroscopic techniques,
such as 1H coupled 13C NMR spectra, APT, HMQC, gs-HSQC,
gs-HMBC, COSY, TOCSY, NOESY and NOE-difference spec-
troscopy [29]. In some cases experiments with selective excita-
tion of certain 1H resonances were performed, such as long-
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Table 1: Multicomponent reaction of various 5-alkynyl-1-phenyl-1H-pyrazole-4-carbaldehydes 1 with p-toluenesulfonyl hydrazide and aldehydes or
ketones 4.
Entry Compound 1 Compound 4 Product 5 Yield, %
1
1a
4a
5a
83
2
1b
4a
5b
47
3
1c
4a
5c
73
4
1d
4a
5d
73
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Table 1: Multicomponent reaction of various 5-alkynyl-1-phenyl-1H-pyrazole-4-carbaldehydes 1 with p-toluenesulfonyl hydrazide and aldehydes or
ketones 4. (continued)
5
1e
4a
5e
44
6
1f
4a
5f
79
7
1a
4b
5g
59
8
1a
4c
5h
73
9
1b
4c
5i
59
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Table 1: Multicomponent reaction of various 5-alkynyl-1-phenyl-1H-pyrazole-4-carbaldehydes 1 with p-toluenesulfonyl hydrazide and aldehydes or
ketones 4. (continued)
10
1a
4d
5j
46
11
1a
4e
5k
64
12
1a
4f
5l
38
range INEPT [30] and 2D(δ,J) long-range INEPT [31],
the  la t te r  exper iments  having  been  used  for  the
unambiguous determination of long-range 13C,1H coupling
constants.
With compound 2a, the tosylhydrazone of starting aldehyde 1a,
(E)-configuration at the C=N double bond follows from an
NOE between the iminyl-H (7.96 ppm) and NH (8.22 ppm) as
well from the size of 1J(N=C–H) (160.7 Hz). In contrast, the
(Z)-configuration and thus cis-position of the lone pair of the
nitrogen and the coupled proton with respect to the C=N double
bond should result in a considerably larger 1J-coupling due to
lone-pair effects, which strongly influence such spin couplings
[32,33].
The target products 5a–l show very consistent signal sets
regarding the invariable part of the molecules. In the 1H NMR
spectra of congeners unsubstituted at position 1 (5b, 5d, 5f, 5i)
the signals due to H-1 and H-4 are split due to a small long-
range coupling (5J(H-1,H-4) ~ 0.8 Hz). The signal of H-4 is
located within a relatively small range, namely between 6.85
and 7.20 ppm. Those compounds unsubstituted at position 8
show the H-8 signal at 7.75–7.91 ppm. Characteristic core
signals in the 13C NMR spectra are those of C-3a (134.8–136.7
ppm), C-4 (95.1–98.3 ppm), C-9 (5j: C-10a, 5k,l: C-11a)
(105.6–114.6 ppm),  C-9a (5j :  C-10b, 5k , l :  C-11b)
(130.4–134.2) and C-9b (5j: C-10c, 5k,l: C-11c) (111.2–112.7
ppm). The other carbon resonances (C-1, C-5, C-8) are influ-
enced by the attached substituents to a somewhat larger extent.
Also the 15N NMR spectra show a uniform pattern: the reso-
nances of N-2 and N-3 are slightly influenced by the substituent
at position 1 with the 1-H derivatives having slightly larger
chemical shifts than those of the corresponding 1-methyl
congeners. The 15N chemical shifts of N-6 and N-7 are some-
what smaller with derivatives 5j–5l having a cycloaliphatic ring
anellated to the concerning pyrazole ring. In Figure 1 the 1H,
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Figure 1: 1H NMR (in italics), 13C NMR and 15N NMR (in bold) chem-
ical shifts of 5d in CDCl3 solution (with numbering of ring atoms).
13C and 15N NMR chemical shifts are displayed for model com-
pound 5d, for which also the numbering of ring atoms is given.
The obtained NMR spectroscopic data are inasmuch valuable as
the availability of reliable, unambiguously assigned chemical
shift data is important as reference material for NMR predic-
tion programs, such as CSEARCH/NMRPREDICT [34,35] or
ACD/C+H predictor [36]. Such programs have become more
and more popular in the past few years, particularly for the
prediction of 13C NMR chemical shifts. However, the quality of
such predictions is highly dependent on the disposability of
authentic reference data of related structures, a criterion which
is frequently not fulfilled for rare or new condensed hetero-
cyclic systems, such as those described here.
Conclusion
In conclusion, we present a simple and nonlaborious method to
access dipyrazolo[1,5-a:4',3'-c]pyridines from easily obtainable
5-alkynyl-1-phenyl-1H-pyrazole-4-carbaldehydes through a
silver triflate catalyzed one-pot tandem reaction with p-toluene-
sulfonyl hydrazide and an appropriate aldehyde or ketone.
Moreover, the novel heterocyclic system was investigated in
great detail by extensive NMR spectroscopic investigations
including also 15N. Further studies to exploit the synthetic
potential as well as the biological activities of the latter com-
pounds are in progress and will be published elsewhere.
Supporting Information
Supporting Information File 1
Experimental details and characterization data.
[http://www.beilstein-journals.org/bjoc/content/
supplementary/1860-5397-8-251-S1.pdf]
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